LIVE SESSION BRIEF Biotechnology $227M Cap Quant: HOLD

Enanta Pharmaceuticals, Inc (ENTA) — Live Session & Technical Brief

Updated Nov 16, 2026 3:10 PM ET · Prev Close $10.99

Pro Workspace
Last Session Price
$10.79 -1.82%
-$0.20 vs $10.99 prior close
Intraday Range
$10.63 – $11.09
Open $11.00
Relative Volume
0.37x Avg
95,270 sh
52-Week Range
$10.05 – $17.15
Benchmark Alpha
+0.16% vs SPY
+0.81% vs QQQ
20-Session Trend -7.5%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-1.82%) in Biotechnology

Enanta Pharmaceuticals, Inc (ENTA) is trading within a tight intraday band at $10.79 (-1.82%, 0.37x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, ENTA is trading in line with the S&P 500 (+0.16% alpha). 14-day RSI stands at 43.0, keeping momentum in a bearish regime.

NEWS 70% Weight
Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences

Watertown, Mass., November 04, 2026--Enanta Pharmaceuticals, Inc. Nasdaq Enta , a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, to

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($10.79) trades relative to 20-day SMA ($11.18) and 50-day SMA ($11.88).

Volume Confirmation
LOW VOLUME (0.37x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

ENTA trading in line with the S&P 500 (+0.16% alpha)
ENTA Session
-1.82%
$10.79
S&P 500 (SPY)
-1.98%
$739.44
Nasdaq 100 (QQQ)
-2.63%
$661.99
Healthcare (XLV)
-0.32%
$188.25
Alpha vs SPY: +0.16% Alpha vs QQQ: +0.81% Alpha vs XLV: -1.50%

Recent ENTA Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$10.33
Short-term support band
Upper Bound
$11.25
Short-term resistance band
Key Inflection Level
$11.18 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $11.18 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (ENTA)

BEARISH MA TREND
RSI (14)
43.0
Bearish
20-Day SMA
$11.18
Below 20d
50-Day SMA
$11.88
Below 50d
MACD Signal
Bullish
MACD -0.27
ADX (14)
21.9
Moderate trend
10d Momentum
+0.28
Positive 10-day momentum

Retail & Crowd Sentiment

Quiet
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Enanta Pharmaceuticals announced the first patient dosing in a Phase 1 study for its investigational RNAi therapeutic, Resolve, for the treatment of chronic hepatitis B.

About Enanta Pharmaceuticals, Inc

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the …

Sector
Healthcare
Market Cap
$227M
Employees
131

Get Instant ENTA Catalyst Alerts

Receive an email alert when ENTA triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

ENTA Session & Catalyst FAQ

Why is ENTA stock trading near flat today?

Enanta Pharmaceuticals, Inc (ENTA) is trading within a tight intraday band at $10.79 (-1.82%, 0.37x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, ENTA is trading in line with the S&P 500 (+0.16% alpha). 14-day RSI stands at 43.0, keeping momentum in a bearish regime.

Is ENTA stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.37x relative volume (low participation). Our multi-factor model currently rates ENTA as HOLD. Review full valuation, quality, and timing signals on the ENTA Buy or Sell Decision Brief →

What is ENTA's intrinsic value and expected trading range?

At $10.79, ENTA's modeled 1-to-3 session range is $10.33 – $11.25, with a key inflection level at $11.18 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the ENTA Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for ENTA?

RSI at 43.0 reflects soft below-midline momentum. ENTA trades at $10.79 relative to its 20-day SMA ($11.18) and 50-day SMA ($11.88), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs